7 Dec 2018
Our charity today launches a landmark new study in a first for UK air ambulances and pre-hospital care in an aim to reduce deaths due to catastrophic bleeding.
Thanks to funding from Barts Charity, Saracens and The Henry Surtees Foundation, the two-year study will look at the effectiveness of using a new blood product in critically injured patients suffering major trauma in London.
The product will consist of red blood cells and plasma, and can be given as a transfusion to patients at risk of bleeding to death before arriving at hospital.